Group A streptococci incubated in human plasma can acquire a plasmin-like enzymatic activity. This process involves at least two bacterial proteins and two human protein cofactors. In this study, the key bacterial proteins were identified by using a series of isogenic mutants of group A isolate, CS101. These studies confirm a key role for the secreted plasminogen activator, streptokinase, and identify the major surface fibrinogen-binding protein as the product of the mrp gene. The requirement for human fibrinogen and plasminogen as key cofactors was also confirmed.
Recent studies from our laboratory have identified a mechain the acquisition of enzymatic activity by group A streptococci via the fibrinogen-plasminogen -dependent pathway. nism by which group A streptococci can interact with the human plasminogen system to acquire a surface protease activity
The surface bacterial fibrinogen-binding protein involved in this pathway has not been unequivocally identified. On the [1 -3] . This pathway involves a coupled system involving two host proteins and at least two bacterial proteins. The bacterial basis of analysis of extracts of a group A isolate, fibrinogenbinding M or M-related proteins were implicated [3] . Expresproteins that have been identified include a surface fibrinogenbinding structure and a secreted plasminogen activator, presion of these gene products (emm, mrp, and enn) in both opacity factor -positive and opacity factor -negative isolates is regusumably streptokinase. Human plasminogen and fibrinogen are also required as key cofactors [1 -3] .
lated by the product of the mga gene [4 -6] . Fibrinogen binding in opacity factor -negative isolates is usually associated The role of streptokinase in the acquisition of enzymatic activity by the bacteria demonstrated an unusual dose depenwith the expressed class I M protein, while in opacity factorpositive isolates, this function tends to be associated with the dence. Unlike the well-established 1:1 stoichiometric ratio between plasminogen and streptokinase required for plasminogen mrp gene product [7, 8] . In these studies, the opacity factorpositive M49 serotype group A isolate, CS101, and isogenic activator activity, the acquisition of surface enzymatic activity continued to increase as the concentration of streptokinase inknockout mutants, in which either the sk, mga, emm, or mrp gene was insertionally inactivated, have been compared for creased [2] . These studies raised concerns that a second bacterial protein coexpressed with streptokinase and potentially presthe ability to acquire enzymatic activity by the fibrinogenplasminogen -dependent pathway. ent as a contaminant in streptokinase preparations might be responsible.
Group A streptococci grown in human plasma could also Materials and Methods acquire surface enzymatic activity [1] . This activity was not observed when the bacteria were grown in plasminogenReagents. Plasminogen-free fibrinogen was purchased from Calbiochem (La Jolla, CA) and further purified to remove trace depleted plasma. These results suggested that endogenously contaminating plasminogen by passage over a lysine-Sepharose produced streptokinase could mediate this reaction, despite becolumn. The synthetic plasmin-selective substrate, H-D-Val-Leuing secreted at much lower levels than required for exogenously Lys-para-nitroanilide (S-2251), was obtained from Kabi Pharadded streptokinase, to result in equivalent generation of bactemacia (Franklin, OH). Normal human plasma was obtained from rial-associated enzymatic activity [1, 3] . Consequently, the the American Red Cross (Toledo), and in all experiments a pool studies described herein were designed to evaluate the effects from 3 separate donor units was used. Human plasminogen was of inactivating the streptokinase gene (sk) in a representative purified from plasma by passage over lysine-Sepharose (Phargroup A isolate, thereby determining the role of streptokinase macia, Piscataway, NJ) as described in [9] .
Iodination of proteins. Proteins were iodinated with [
125
Insertional inactivation of the streptokinase gene. The specific remove unbound proteins by addition of the plasmin-selective substrate S-2251 (400 mM). After 30 min of incubation at 37ЊC, the inactivation of the streptokinase gene (sk) was done by using a recombinant integration vector pSF152 following the general stratbacteria were pelleted, and the substrate cleavage in 100 mL of bacterium-free supernatant was measured by reading the abegy described previously [5, 11] broth. Fibrinogen-binding proteins were solubilized by treatment of bacteria with CNBr by use of procedures previously described The PCR product was then cloned into pSF152, and thereafter, the insertional inactivation and screening strategy followed that by our laboratory [15] . For analysis of the mga
isogenic mutants, organisms were grown in the presence of 60 mg/ described in [5] .
Cloning and expressing of streptokinase gene from isolate mL spectinomycin and then extracted with CNBr as described [15] . CS101. The streptokinase gene was amplified from the streptococcal DNA of CS101 by PCR using equal amounts of the followExpression of fcrA49, emm49, and enn49 genes. The fcrA49, emm49, and enn49 genes of isolate CS101 were cloned into the ing primers, which were designed on the basis of published sequence data of the streptokinase gene from group A streptococci pJLA602 vector and expressed in E. coli as described previously [11, 13] . Sonicates of E. coli were centrifuged at 8000 g for 5 min [12] . The primers corresponded to the sequence encoding the amino-and carboxy-termini of the mature streptokinase protein:
to remove insoluble material, and the supernatant material was treated with CNBr as described [15] . A control sonicate of E. coli forward primer, 5 -GGGGGGGGATCCAATGGGGATTGA -AACTTA-3; reverse primer, 5-GGGGGGGTCGACTCGTTTalone or E. coli containing the pJLA602 plasmid lacking an insert were included as negative controls. TAGAAGATCGTG-3. The PCR reaction was done under the following conditions: 95ЊC for 2 min, then 5 cycles of 95ЊC for 1
Western immunoblotting. Protein samples were separated by 10% SDS-PAGE under reducing conditions using the Laemmli min, 47ЊC for 1 min, and 72ЊC for 2.5 min, followed by 25 cycles of 95ЊC for 1 min, 55ЊC for 1 min, and 72ЊC for 2.5 min. The buffer system and then electrophoretically transferred to nitrocellulose (Bio-Rad) by a modification of the method described by Towfinal PCR product was then electrophoresed in a 1% agarose gel and purified from the gel using a kit (QIAEX Gel Purification bin et al. [16] . Briefly, SDS slab gels were presoaked for 30 min in 25 mM TRIS-HCl, 192 mM glycine, and 20% methanol (pH Kit; Qiagen, Chatsworth, CA) according to the manufacturer's directions. The purified product was then digested with both 8.3), assembled into the high-field intensity electrophoresis system (Transblot; Bio-Rad), and electrophoresed in that buffer at 70 V BamHI and SalI, ligated into plasmid pJLA602 (Medac, Hamburg, Germany), and transformed into competent Escherichia coli host for 3 h. The nitrocellulose blots were washed four times with 250 mL of 50 mM veronal buffer, pH 7.4, containing 0.15 M NaCl, strain DH5a [13] . Transformants were detected by their ability to grow on media containing ampicillin (50 mg/mL) and then 0.25% gelatin, and 0.25% Tween 20 to saturate remaining proteinbinding sites on the nitrocellulose. The nitrocellulose membranes screened for the presence of an appropriately sized insert. Selected transformants were grown in ampicillin-containing LB medium were then incubated with either 125 I-or biotin-labeled probes at room temperature for 3 h. After incubation, the membranes were (50 mg/mL) to late logarithmic phase at 28ЊC. Expression of streptokinase was then induced by temperature shift to 42ЊC. After a washed and dried, and bound probe was detected either by autoradiography (for 125 I-labeled probes) using Kodak XAR-5 film and 2-to 3-h incubation period, bacteria were harvested and sonicates screened for functional plasminogen activator activity as described Kodak X-omatic intensifying screens at 070ЊC or by use of a streptavidin-horseradish peroxidase reporter (for biotinylated below. Samples of sonicates containing the pJLA plasmid without an insert were included as a control in each assay using recombiprobes) and a chemiluminescence kit (ECL; Amersham). nant streptokinase.
Measurement of plasminogen activator activity. Streptokinase activity was measured in a microtiter plate format by use of a Results modification of the assay described by Kulisek et al. [14] . Briefly, 50 mL of an overnight culture supernatant of CS101 or an isogenic
The initial studies compared an M49 group A streptococcal mutant of CS101 in which the sk gene was inactivated was mixed isolate, CS101, and an isogenic mutant in which the streptokiwith 6 mg of purified human plasminogen or buffer and incubated nase gene was insertionally inactivated for their ability to acat 37ЊC for 30 min. After this incubation step, 100 mL of the quire enzymatic activity when incubated in the presence of plasmin-selective synthetic substrate S-2251 was added to each human fibrinogen and plasminogen. The wild type organism well to a final concentration of 400 mM and incubated at 37ЊC.
was found to secrete a functional plasminogen activator in The wild type and isogenic streptokinase knockout mutant
Assays for acquisition of bacterial surface-associated enzyme
were then compared for their ability to acquire enzymatic activactivity. Bacterium-associated enzymatic activity was measured as described previously [2, 3] , after washing of the bacteria to ity after incubation with a source of human fibrinogen (50 mg/ / 9d27$$my16 02-28-97 16:55:02 jinfa UC: J Infect Figure 1 . Analysis of role of streptokinase (SK) in facilitating acquisition of plasmin-like protease activity by group A streptococci incubated with human fibrinogen and plasminogen. A, Analysis of plasminogen activator activity. B, Analysis of ability of wild type CS101 (wt) and isogenic sk 0 mutant to acquire surface enzymatic activity. THB, Todd-Hewitt broth; Fg, fibrinogen; Plg, plasminogen; rSKa, recombinant group A streptokinase. mL) and plasminogen (2 mg/mL) at 37ЊC for 6 h. The results the surface of group A streptococci has not been unequivocally identified; however, fibrinogen-binding M and M-related gene presented in figure 1B demonstrate that the wild type but not the isogenic sk 0 mutant could acquire enzymatic activity when products encoded by genes present within the mga regulon of group A streptococci would be potential candidates [7, 8 , incubated with fibrinogen and plasminogen. This activity was absolutely dependent on the presence of both plasminogen and 17 -19] . To test this prediction, an isogenic mutant of isolate CS101, in which the mga gene had been insertionally inactifibrinogen in the reaction mixture ( figure 1B) .
The ability of the sk 0 mutant to acquire enzymatic activity vated, was studied. Previous studies have demonstrated that this mga regulon knockout mutant failed to express detectable could be restored by addition of a source of purified recombinant streptokinase cloned from isolate CS101 (figure 1B). In surface M or M-related proteins without a detectable change in the quantity of streptokinase secreted into the culture media this experiment, addition of exogenous streptokinase to the wild type organisms enhanced their ability to acquire enzymatic [5, 20] . The mga 0 mutant and its isogenic wild type parent were compared for their ability to bind fibrinogen or acquire activity, indicating that production of the plasminogen activator was the limiting factor in this system. No enzymatic activity enzymatic activity when incubated in the presence of fibrinogen, plasminogen, and exogenous streptokinase for 30 min was acquired by either the wild type or the sk 0 mutant unless all three components (plasminogen, fibrinogen, and streptokinase) at 37ЊC. The results presented in figure 2A demonstrate that the wild were present in the reaction mixture during the incubation period (data not shown).
type organisms bound fibrinogen efficiently compared with binding by the isogenic mga 0 mutant. The mutant bound Ç75% Previous studies had demonstrated that acquisition of enzymatic activity by group A streptococci followed a sequential less fibrinogen than the wild type organism ( figure 2A ). The ability of these isolates to acquire enzymatic activity when pathway in which fibrinogen bound to the bacteria and provided a site for binding of a streptokinase-plasminogen complex incubated with combinations of fibrinogen, streptokinase, and plasminogen was also tested. Acquisition of enzymatic activity [2, 3] . Fibrinogen-coated bacteria could bind neither streptokinase alone nor plasminogen alone but could bind a complex in this system can be attributed to two distinct pathways [8] : first, the binding of fluid-phase plasmin to plasmin-binding when both proteins were present together in the fluid phase [3] . These studies have been repeated with isolate CS101, and structures on the surface of bacteria, and second, the fibrinogendependent pathway. a similar pattern of reactivity was observed. These results indicate that the key surface-associated bacterial structure was a
To minimize the contributions of the direct binding pathway in these experiments, a 2 -antiplasmin was added to the reaction fibrinogen-binding protein (data not shown).
The key fibrinogen-binding protein responsible for providing mixture. This enabled the contribution of the acquired cell surface enzymatic activity attributable to the fibrinogen-depenthe anchoring site for a streptokinase-plasminogen complex to Figure 2 . Analysis of wild type CS101 (wt) and isogenic mutant in which mga gene was insertionally inactivated. A, Binding of radiolabeled human fibrinogen to group A isolate CS101 or mga 0 isogenic mutant. B, Comparison of wt CS101 and paired isogenic mga 0 mutant for ability to acquire surface enzymatic activity when incubated with human plasminogen (Plg) and fibrinogen (Fg). rSKa, recombinant group A streptokinase. dent pathway to be measured by difference. The results prenor the IgG 3 -binding emm49 gene product demonstrated significant reactivity with fibrinogen. sented in figure 2B demonstrate an Ç60% reduction in the ability of mga 0 mutant organisms to acquire surface enzymatic The ability of fibrinogen bound to Mrp49 to anchor streptokinase-plasminogen complexes was tested in the next series of activity attributable to the fibrinogen-dependent pathway compared with the surface enzymatic activity of wild type organstudies. The results presented in figure 3 demonstrate that Mrp49 immobilized on a nitrocellulose blot was capable of isms. These studies demonstrated that an mga regulon gene product(s) was responsible for the majority of the surface fibinding labeled plasminogen only when both streptokinase and fibrinogen were present in the probing mixture. No significant brinogen-binding phenotype of this organism and that there was a clear association between binding of fibrinogen by the binding of either labeled plasminogen alone or streptokinase alone was detected to any of the M or M-related gene products organism and its ability to acquire a plasmin(ogen)-dependent enzymatic activity.
tested (data not shown).
In parallel studies using unlabeled proteins, the fibrinogenTo identify the mga regulon product(s) responsible for fibrinogen binding and anchoring enzymatic activity, mrp49, streptokinase-plasminogen complex bound to Mrp49 was shown to have enzymatic activity and could hydrolyze the emm49, and enn49 genes, cloned from group A isolate CS101, were expressed and tested for reactivity with fibrinogen. The plasmin-selective synthetic substrate S-2251. If any one of the three proteins was omitted from the reaction mixture, no results of these studies, presented in figure 3 , demonstrate (in agreement with previous studies [8] ) that the mrp gene product immobilized enzymatic activity could be detected (data not shown). bound fibrinogen. Neither the IgA-binding enn49 gene product 5 cpm/mL) alone (left), with mixture of streptokinase (SK; 400 U/mL) and biotinylated plasminogen (PLG; 2 mg/mL) (center), or with fibrinogen (50 mg/mL) followed by mixture of streptokinase (400 U/mL) and biotinylated plasminogen ( 2 mg/mL) (right). Molecular masses are indicated at left.
/ 9d27$$my16
02-28-97 16:55:02 jinfa UC: J Infect Taken together, all of the results presented in this study are human plasma could acquire surface plasmin-like enzymatic consistent with the mrp gene product serving as the major cell activity [1] . Analysis of this pathway identified a critical role surface fibrinogen-binding structure, which provides a binding for at least two bacterial proteins, a surface fibrinogen-binding site for streptokinase-plasminogen complexes, enabling the orprotein and the secreted plasminogen activator streptokinase, ganism to anchor an unregulated cell surface form of a potent as well as two human proteins, fibrinogen and plasminogen host protease. [2, 3] . In this study, the identity of the key bacterial components To test this prediction directly, a series of studies similar to in the fibrinogen-plasminogen-streptokinase pathway were those described for figure 2 was repeated with isogenic mutants studied by use of a wild type opacity factor -positive M49 in which either the emm gene or the mrp gene of isolate CS101 serotype group A isolate, CS101, and selected isogenic muwas insertionally inactivated. The results presented in figure tants. 4A demonstrate that inactivation of the mrp gene resulted in
In the initial experiments, the ability of the wild type and a significant loss of fibrinogen binding to isolate CS101 coman isogenic sk 0 mutant to acquire enzymatic activity in the pared with fibrinogen binding of the wild type organism. By presence of fibrinogen and plasminogen were compared. Enzycontrast, inactivation of the emm gene resulted in a small inmatic activity was acquired only by the wild type organism, crease in fibrinogen binding compared with that of the wild indicating a key role for the sk gene product. Addition of type organism, presumably because of enhanced expression of recombinant streptokinase, cloned from isolate CS101, restored Mrp due to the absence of surface expression of an emm gene the ability of the sk 0 mutant to acquire enzymatic activity in product. As expected, the surface enzymatic activity acquired the presence of human fibrinogen and plasminogen. In studies by the mutants via the fibrinogen-dependent pathway paralleled in which the wild type bacteria were incubated with combinathe fibrinogen-binding properties of each organism ( figure 4B) .
tions of fibrinogen, recombinant streptokinase, and/or plasminThe results obtained with the mga 0 and the mrp 0 mutant were ogen in a different sequential order, the first step in acquiring equivalent, further supporting the conclusion that the mrp surface enzymatic activity was identified as the binding of gene product of isolate CS101 is the major surface fibrinogenfibrinogen to a cell surface fibrinogen-binding protein. The cellbinding structure for this organism and that Mrp provided this bound fibrinogen provided an anchoring site for a streptokiisolate with the ability to acquire cell surface enzymatic activity nase-plasminogen complex but failed to bind either streptokivia a fibrinogen-plasminogen-streptokinase pathway.
nase or plasminogen offered separately. Analysis of the fibrinogen-binding properties of CS101 demonstrated that the major surface fibrinogen-binding protein was Discussion coded for by a gene within the mga regulon. Inactivation of the mga gene resulted in an Ç75% reduction in fibrinogen Previous studies from our laboratory had demonstrated a complex pathway by which group A streptococci grown in binding, which was paralleled by an equivalent loss in the
